These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13778445)

  • 41. [KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions].
    Voronina EN; Vikhrova MA; Khrapov EA; Kinsht VN; Norkina OV; Gorbunova EV; Shabaldin AV; Glushkov AN; Krasnov VA; Filipenko ML
    Mol Gen Mikrobiol Virusol; 2004; (3):8-11. PubMed ID: 15354935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on double or triple resistance of Mycobacterium tuberculosis. 1. The rate of appearance of double or triple resistance, and the effect of drugs on the appearance of this resistance].
    KUROIWA K
    Kekkaku; 1960 Jul; 35():492-8. PubMed ID: 13755309
    [No Abstract]   [Full Text] [Related]  

  • 43. Antimycobacterial activity of N-isonicotinyl hydrazide and cross resistance to isoniazid.
    KLUGH GA; PRATT PC; ATWELL RJ
    Am Rev Respir Dis; 1960 Aug; 82():251-2. PubMed ID: 14410011
    [No Abstract]   [Full Text] [Related]  

  • 44. [A study on the construction of population of isoniazid-resistant strain and its back mutation in Mycobacterium tuberculosis].
    MIURA K
    Kekkaku; 1956 Oct; 31(10):616-20. PubMed ID: 13377512
    [No Abstract]   [Full Text] [Related]  

  • 45. Prelimianry observations on the increase in isoniazid resistance of M. tuberculosis H37RV after exposure to an extract of tuberculous tissue.
    URBANCIK R; TRNKA L
    Am Rev Respir Dis; 1962 Apr; 85():596-8. PubMed ID: 13923896
    [No Abstract]   [Full Text] [Related]  

  • 46. [Influence of the inhibition of the growth of Koch's bacilli by the serum of tuberculous patients on the exactitude of the results of determination of active isoniazid].
    PREGOWSKI W; ZUKOWSKA H
    Rev Tuberc Pneumol (Paris); 1960 Dec; 24():1372-5. PubMed ID: 13737818
    [No Abstract]   [Full Text] [Related]  

  • 47. [Resistence to experimental tuberculous infection in guinea pigs infected with virulent Mycobacterium tuberculosis and treated with isoniazid].
    GROSSO E; ATTILI L
    Boll Ist Sieroter Milan; 1959; 38():329-34. PubMed ID: 13851799
    [No Abstract]   [Full Text] [Related]  

  • 48. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
    Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Percentage of isoniazid-resistant and streptomycin-resistant variants in wild strains of Mycobacterium tuberculosis on Loewenstein-Jensen medium].
    CANETTI G; GROSSET J
    Ann Inst Pasteur (Paris); 1961 Jul; 101():28-46. PubMed ID: 13690427
    [No Abstract]   [Full Text] [Related]  

  • 50. [The antibacterial action in vivo of a single therapeutic dose of isoniazid in mice infected with Mycobacterium tuberculosis labeled with radiocarbon C-14].
    MAURO B; PASQUIER JF
    Ann Ist Carlo Forlanini; 1960; 20():412-7. PubMed ID: 13768453
    [No Abstract]   [Full Text] [Related]  

  • 51. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid.
    Deretic V; Philipp W; Dhandayuthapani S; Mudd MH; Curcic R; Garbe T; Heym B; Via LE; Cole ST
    Mol Microbiol; 1995 Sep; 17(5):889-900. PubMed ID: 8596438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the potential role of a new mutation in mabA in modifying the response of Mycobacterium tuberculosis to isoniazid.
    Alonso M; Martínez-Lirola M; Palacios JJ; Menéndez Á; Herranz M; Martínez S; Bouza E; García-de-Viedma D
    Tuberculosis (Edinb); 2013 Nov; 93(6):664-7. PubMed ID: 23973657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of hextuple resistance to aminoglycoside antibiotics in Mycobacterium tuberculosis (H37RV) by mutation to isoniazid resistance and by incubation at high temperature.
    Tsukamura M
    J Gen Microbiol; 1977 Feb; 98(2):611-4. PubMed ID: 404392
    [No Abstract]   [Full Text] [Related]  

  • 54. Late emergence of isoniazid-susceptible organisms in guinea pigs challenged with a homogeneous isoniazid-resistant strain on Mycobacterium tuberculosis.
    Noufflard-Guy-Loe H; Berteaux S
    Am Rev Respir Dis; 1966 Oct; 94(4):540-52. PubMed ID: 4958873
    [No Abstract]   [Full Text] [Related]  

  • 55. Peroxidase activity and INH resistance in M. tuberculosis.
    JUHLIN I
    Acta Pathol Microbiol Scand Suppl; 1962; Suppl 154():280-1. PubMed ID: 14452734
    [No Abstract]   [Full Text] [Related]  

  • 56. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis.
    Rinder H; Thomschke A; Rüsch-Gerdes S; Bretzel G; Feldmann K; Rifai M; Löscher T
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):508-11. PubMed ID: 9764555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia].
    Llerena C; Medina R
    Biomedica; 2017 Jan; 37(1):28-33. PubMed ID: 28527245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The influence in vitro of isoniazid on the liberation of C-14 radiocarbon from tubercular mycobacteria previously labeled with this radio-element].
    MAURO B; PASQUIER JF; LUCEL J
    Ann Ist Carlo Forlanini; 1961; 21():74-80. PubMed ID: 14471587
    [No Abstract]   [Full Text] [Related]  

  • 59. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains.
    Ristow M; Möhlig M; Rifai M; Schatz H; Feldmann K; Pfeiffer A
    Lancet; 1995 Aug; 346(8973):502-3. PubMed ID: 7637495
    [No Abstract]   [Full Text] [Related]  

  • 60. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.